{"id":75328,"date":"2026-08-19T12:43:26","date_gmt":"2026-08-19T04:43:26","guid":{"rendered":"https:\/\/flcube.com\/?p=75328"},"modified":"2026-08-19T12:43:30","modified_gmt":"2026-08-19T04:43:30","slug":"trump-picks-white-house-policy-advisor-heidi-overton-to-lead-fda-replacing-acting-commissioner-kyle-diamantas-after-makarys-resignation","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=75328","title":{"rendered":"Trump Picks White House Policy Advisor Heidi Overton to Lead FDA \u2013 Replacing Acting Commissioner Kyle Diamantas After Makary&#8217;s Resignation"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">U.S. President <strong>Donald Trump<\/strong> has chosen White House policy advisor <strong>Heidi Overton<\/strong> to lead the <strong>Food and Drug Administration (FDA)<\/strong>, Reuters reported on August 18, a decision with far\u2011reaching implications for pharmaceutical regulation, vaccine policy, and drug review at one of the world&#8217;s most influential health agencies.<\/p>\n\n\n\n<h2 id=\"h-appointment-summary\" class=\"wp-block-heading\">Appointment Summary<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Nominee<\/strong><\/td><td>Heidi Overton<\/td><\/tr><tr><td><strong>Current Role<\/strong><\/td><td>Deputy Director, White House Domestic Policy Council<\/td><\/tr><tr><td><strong>Background<\/strong><\/td><td>Physician by training; previously at the conservative think tank <strong>America First Policy Institute<\/strong><\/td><\/tr><tr><td><strong>Position<\/strong><\/td><td>FDA Commissioner (nominee)<\/td><\/tr><tr><td><strong>Reported By<\/strong><\/td><td>Reuters, 18 Aug 2026<\/td><\/tr><tr><td><strong>Predecessor<\/strong><\/td><td>Marty Makary (resigned May 2026)<\/td><\/tr><tr><td><strong>Interim Leadership<\/strong><\/td><td>Kyle Diamantas, acting commissioner since Makary&#8217;s departure<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-leadership-transition-at-the-fda\" class=\"wp-block-heading\">Leadership Transition at the FDA<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Makary&#8217;s Departure:<\/strong> Former FDA Commissioner <strong>Marty Makary resigned in May 2026<\/strong>, ending a tenure marked by regulatory controversy<\/li>\n\n\n\n<li><strong>Interim Period:<\/strong> <strong>Kyle Diamantas<\/strong> has served as <strong>acting commissioner<\/strong> since Makary&#8217;s exit<\/li>\n\n\n\n<li><strong>Overton&#8217;s Profile:<\/strong> A doctor by training, Overton currently serves as <strong>Deputy Director of the White House Domestic Policy Council<\/strong> and previously worked at the conservative think tank <strong>America First Policy Institute<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-criticism-facing-makary-s-tenure\" class=\"wp-block-heading\">Criticism Facing Makary&#8217;s Tenure<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Makary drew criticism on several fronts during his leadership of the FDA:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Issue<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Flavored Vapes<\/strong><\/td><td>Handling of the reintroduction of flavored vapes into the U.S. market<\/td><\/tr><tr><td><strong>Abortion Pills<\/strong><\/td><td>A stalled review of abortion pills<\/td><\/tr><tr><td><strong>Industry Disputes<\/strong><\/td><td>Public disagreements with pharmaceutical companies \u2014 including <strong>Replimune<\/strong>, <strong>Sarepta<\/strong>, and <strong>Moderna<\/strong> \u2014 regarding reviews of potentially lifesaving drugs and vaccines<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-market-impact-amp-outlook\" class=\"wp-block-heading\">Market Impact &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Regulatory Reset Signal:<\/strong> Overton&#8217;s nomination marks another pivot in FDA leadership at a time when the agency&#8217;s relationship with the pharmaceutical industry has grown increasingly contentious, raising questions about review timelines for pending drugs and vaccines.<\/li>\n\n\n\n<li><strong>Industry Watch:<\/strong> Public disputes involving <strong>Replimune, Sarepta, and Moderna<\/strong> under Makary have made the FDA&#8217;s independence in drug review a focal point for investors; the incoming commissioner&#8217;s stance on these reviews will be closely monitored.<\/li>\n\n\n\n<li><strong>Policy Continuity:<\/strong> Overton&#8217;s White House Domestic Policy Council role and America First Policy Institute background suggest alignment with the administration&#8217;s health policy agenda, potentially accelerating changes in areas such as tobacco\/vape regulation and reproductive health product reviews.<\/li>\n\n\n\n<li><strong>Watch Items:<\/strong> Senate confirmation timeline, Overton&#8217;s stated priorities on drug approval standards, and any near\u2011term shifts in ongoing reviews that had stalled or drawn industry criticism under the prior leadership.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward-Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding the FDA leadership transition and its potential regulatory implications. Actual results may differ due to risks including confirmation proceedings, policy decisions, and institutional dynamics within the FDA.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>U.S. President Donald Trump has chosen White House policy advisor Heidi Overton to lead the&#8230;<\/p>\n","protected":false},"author":1,"featured_media":75331,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[4],"tags":[],"class_list":["post-75328","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-policy-regulatory"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Trump Picks White House Policy Advisor Heidi Overton to Lead FDA \u2013 Replacing Acting Commissioner Kyle Diamantas After Makary&#039;s Resignation - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"U.S. President Donald Trump has chosen White House policy advisor Heidi Overton to lead the Food and Drug Administration (FDA), Reuters reported on August 18, a decision with far\u2011reaching implications for pharmaceutical regulation, vaccine policy, and drug review at one of the world&#039;s most influential health agencies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=75328\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Trump Picks White House Policy Advisor Heidi Overton to Lead FDA \u2013 Replacing Acting Commissioner Kyle Diamantas After Makary&#039;s Resignation\" \/>\n<meta property=\"og:description\" content=\"U.S. President Donald Trump has chosen White House policy advisor Heidi Overton to lead the Food and Drug Administration (FDA), Reuters reported on August 18, a decision with far\u2011reaching implications for pharmaceutical regulation, vaccine policy, and drug review at one of the world&#039;s most influential health agencies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=75328\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-19T04:43:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-19T04:43:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1901.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75328#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75328\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Trump Picks White House Policy Advisor Heidi Overton to Lead FDA \u2013 Replacing Acting Commissioner Kyle Diamantas After Makary&#8217;s Resignation\",\"datePublished\":\"2026-08-19T04:43:26+00:00\",\"dateModified\":\"2026-08-19T04:43:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75328\"},\"wordCount\":442,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75328#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/1901.webp\",\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=75328#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75328\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=75328\",\"name\":\"Trump Picks White House Policy Advisor Heidi Overton to Lead FDA \u2013 Replacing Acting Commissioner Kyle Diamantas After Makary's Resignation - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75328#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75328#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/1901.webp\",\"datePublished\":\"2026-08-19T04:43:26+00:00\",\"dateModified\":\"2026-08-19T04:43:30+00:00\",\"description\":\"U.S. President Donald Trump has chosen White House policy advisor Heidi Overton to lead the Food and Drug Administration (FDA), Reuters reported on August 18, a decision with far\u2011reaching implications for pharmaceutical regulation, vaccine policy, and drug review at one of the world's most influential health agencies.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75328#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=75328\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75328#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/1901.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/1901.webp\",\"width\":1080,\"height\":608,\"caption\":\"Trump Picks White House Policy Advisor Heidi Overton to Lead FDA \u2013 Replacing Acting Commissioner Kyle Diamantas After Makary's Resignation\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75328#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Trump Picks White House Policy Advisor Heidi Overton to Lead FDA \u2013 Replacing Acting Commissioner Kyle Diamantas After Makary&#8217;s Resignation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Trump Picks White House Policy Advisor Heidi Overton to Lead FDA \u2013 Replacing Acting Commissioner Kyle Diamantas After Makary's Resignation - Insight, China&#039;s Pharmaceutical Industry","description":"U.S. President Donald Trump has chosen White House policy advisor Heidi Overton to lead the Food and Drug Administration (FDA), Reuters reported on August 18, a decision with far\u2011reaching implications for pharmaceutical regulation, vaccine policy, and drug review at one of the world's most influential health agencies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=75328","og_locale":"en_US","og_type":"article","og_title":"Trump Picks White House Policy Advisor Heidi Overton to Lead FDA \u2013 Replacing Acting Commissioner Kyle Diamantas After Makary's Resignation","og_description":"U.S. President Donald Trump has chosen White House policy advisor Heidi Overton to lead the Food and Drug Administration (FDA), Reuters reported on August 18, a decision with far\u2011reaching implications for pharmaceutical regulation, vaccine policy, and drug review at one of the world's most influential health agencies.","og_url":"https:\/\/flcube.com\/?p=75328","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-08-19T04:43:26+00:00","article_modified_time":"2026-08-19T04:43:30+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1901.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=75328#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=75328"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Trump Picks White House Policy Advisor Heidi Overton to Lead FDA \u2013 Replacing Acting Commissioner Kyle Diamantas After Makary&#8217;s Resignation","datePublished":"2026-08-19T04:43:26+00:00","dateModified":"2026-08-19T04:43:30+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=75328"},"wordCount":442,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=75328#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1901.webp","articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=75328#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=75328","url":"https:\/\/flcube.com\/?p=75328","name":"Trump Picks White House Policy Advisor Heidi Overton to Lead FDA \u2013 Replacing Acting Commissioner Kyle Diamantas After Makary's Resignation - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=75328#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=75328#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1901.webp","datePublished":"2026-08-19T04:43:26+00:00","dateModified":"2026-08-19T04:43:30+00:00","description":"U.S. President Donald Trump has chosen White House policy advisor Heidi Overton to lead the Food and Drug Administration (FDA), Reuters reported on August 18, a decision with far\u2011reaching implications for pharmaceutical regulation, vaccine policy, and drug review at one of the world's most influential health agencies.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=75328#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=75328"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=75328#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1901.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1901.webp","width":1080,"height":608,"caption":"Trump Picks White House Policy Advisor Heidi Overton to Lead FDA \u2013 Replacing Acting Commissioner Kyle Diamantas After Makary's Resignation"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=75328#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Trump Picks White House Policy Advisor Heidi Overton to Lead FDA \u2013 Replacing Acting Commissioner Kyle Diamantas After Makary&#8217;s Resignation"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1901.webp","_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/75328","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=75328"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/75328\/revisions"}],"predecessor-version":[{"id":75332,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/75328\/revisions\/75332"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/75331"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=75328"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=75328"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=75328"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}